We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-2 of 2

FDA’s draft public disclosure proposals and their potential impact on product liability litigation
  • Dechert LLP
  • USA
  • July 6 2010

A task force of the U.S. Food and Drug Administration (FDA), in conjunction with the Obama Administration’s Open Government initiative, recently released 21 draft proposals that would broaden FDA’s public disclosure policies